black man having conversation with psychologist

Innovation in Healthcare Management

2.1 Definition and Types of Innovation in Healthcare Management

‘Innovation’ simply refers to new, better and more effective ways of solving problems (McSherry & Douglas., 2011). The concept of innovation is widely used in business management, technology and marketing domains, and the term is mostly used to describe strategies, products, services, policies, systems and internet communication technology (ICT) that provide solutions to existing organizational problems (Wutzke et al., 2016). Thus, ‘innovation’ in healthcare management is associated with new ideas, process and technology adapted to solve health care problems. But many researchers have viewed the concept from different perspectives because recent developments in diagnostic and therapeutic options—among other care delivery models—have led to an outburst of innovations designed to improve quality of life and life expectancy (Omachonu & Einspruch., 2010). For example, innovation can be viewed from a social perspective if the aim is to solve social issues such as poverty, education, health, and other of high-impact problems that negatively affect human development through system-level changes (Schweitzer et al., 2015).

The U.S. Department of Commerce Advisory Committee on Measuring Innovation in the 21st Century Economy defined innovation as the act of ‘designing, inventing, developing and/or implementing new or modified products, services, processes, organizational structures, systems, or business models in order to create new value for stakeholders/customers and increase profit for the organization.’ The World Health Organization (WHO) (2016) views ‘health innovation’ as a strategy to enhance the efficiency, effectiveness, safety, quality, sustainability, and affordability of health care. Viewed comprehensively, this definition includes implementation of new health policies, practices, systems, products/services, technologies and optimized delivery methods that guarantee provision of quality, accessible and cheap health care services (Assink., 2006; Länsisalmi et al., 2006; Langley et al., 2009; Hemphälä & Magnusson., 2012).

Basically, innovation is focused on improving work process and systems to deliver quality services to customers. Innovation in healthcare management can also mean new ways of building and sustaining relationship with care users or workable approaches adapted to market healthcare products and services (Omachonu & Einspruch., 2010). But despite the interrelatedness of definitions, modern-day healthcare organizations are facing unprecedented challenges to improve quality of care, eliminate waste of human and material resources, reduce harm to health care workers and care users, improve access to care and work tools, as well as increase efficiency and lower costs for both health providers and care users. Innovation has therefore taken centre stage in healthcare management once again (Greenhalgh et al., 2004). The major problem is there is no clear definition of innovation in healthcare management due to lack of consensus—and this is an obstacle to adapting innovation in clinical practices, policymaking and primary care delivery. The concept of innovation has been frequently misconstrued and inappropriately used in many countries to describe different developments within healthcare (Rogers., 2003; Dubé et al., 2014; Wu et al., 2019).

Types of Innovation in Healthcare Management

Innovation in healthcare management is best analysed by its impact on stakeholders. In this context, innovation can be either non-disruptive or disruptive (Christensen et al., 2000).

Disruptive Innovation: This refers to radical, transformational or revolutionary strategies of creating new markets to deliver dramatic new value opportunities. Disruptive innovation is widely used by entrepreneurs–particularly in Silicon Valley—to describe events such as tech start-ups toppling bigger organizations. The theory of disruptive innovation was invented by a Harvard Business School professor, Clayton Christensen, who acknowledged that the concept is misconstrued and erroneously applied to businesses that are not truly disruptive. According to Christensen et al. (2006), Uber is commonly cited as an example of disruptive innovation due to its revolutionary presence in the taxi-cab industry. Christensen, who coined the term in a 1997 masterpiece titled ‘The Innovator’s Dilemma,’ the ride-hailing app does not represent true disruptive innovation. In 2015, Christensen—in partnership with Michael Raynor and Rory McDonald—wrote another article for the Harvard Business Review for the purpose of squashing the confusion about disruptive innovation (Christensen et al., (2015). The scholars, thus, defined it as ‘gaining competitive advantage against bigger organizations by targeting segments of the market neglected by competitors whose focus is on more profitable areas.’ This implies that innovation is not just about improving products and services but exploiting new areas previously neglected by industry leaders (Christensen., 1995; Ab Rahman et al., 2017).

On this backdrop, disruptive innovation in healthcare management is defined as ‘the application of advanced technology in clinical research.’ It also refers to strategies adapted to enhance user experience through new healthcare system that provides more accessible and individualized services. Fundamentally, disruptive innovations in healthcare influence introduction of new systems that provide a continuum of care focused on handling each patient’s health needs—instead of concentrating more on urgent health crises and complex disorders. Advanced diagnostic and therapeutic technologies have therefore empowered nurses and physician assistants to competently diagnose and treat disorders that previously required presence of a physician (Lardner., 1998; Christensen et al., 2016).

Figure 2.3 Disruptive Innovation by Low-end Organizations

Adapted from Clayton Christensen (1997)

Some examples of disruptive innovations are:

  • Consumer devices, wearables and apps: Previous innovations in healthcare management only allowed patients to get their biometric data, heart rate, pulse, blood pressure and blood oxygen from the doctor’s office (Riaz et al., 2018). New technologies allow care users to take control of their own health. Although physicians use data gathered from wearables and apps to make treatment decisions, there are legal and ethical concerns about the security of data shared over the internet (Han & Koo., 2021).
  • Artificial Intelligence (AI) and machine learning: AI technologies have significantly improved management of patient data, scheduling, billing etc. For example, chatbots with natural language processing system can answer questions from care users 24/7, thus, bridging communication distance, saving time, and reducing costs. AI applications ultimately help doctors and staff to focus on patient care (Dhamija & Bag., 2020).
  • Internet of Things (IoT): IoT enhances use of data collated from wearables, sensors, apps and other devices to discover disease clusters and accurately suggest effective solutions (Wheeler & Buckley., 2021).
  • Blockchain: This area of innovation in healthcare management focuses on database technology—particularly how security measures such as encryption can be applied to ensure security of data received, stored and shared between patients and health providers (Fortino et al., 2020; Wang et al., 2021).
  • Big data and electronic health records (EHRs): EHRs are an integral part of patient care. The focus is on how EHR data can be safely used in research to improve care, expand and create new business opportunities, and build AI applications (Sun et al., 2021).

Non-disruptive Innovation: Although innovation is crucial for business survivability, organizations must recognize that application of innovative strategies can improve or diminish competitiveness. However, proponents of disruptive innovative argue that organizations must assume the position of a disruptor in order to avoid disruption. But evidence-based research shows disruption can inflict damages on both the disrupter and companies being disrupted. Non-disruptive innovation is focused on sustaining existing strategies or simply improving something that already exists to continually achieve new, better opportunities or solve known issues. Basically, non-disruptive innovation occurs when a company delves into a new market without displacing competitors—because there was none in the segment before. Some multibillion-dollar industries have been established in recent years through non-disruptive creation (e.g. health clubs, Viagra, online dating, microfinance, routers, ringtones, crowdfunding, network devices and switches, among others) (Cai., 2017; Chen et al., 2019).

Non-disruptive innovation is widely overlooked even though it explores new business horizons without negative impact on workers (such as downsizing) or displacement of established brands. Thus, managers who perceive innovation as a disruptive strategy tend to underrate broad opportunities for growth, and modern-day healthcare organizations cannot afford to fail from biased thinking (Stary., 2014).

A myriad of literature in health care management has studied healthcare creations such as new diagnostic procedures, drugs, therapies, and medical devices ranging from wearables, apps, sensors, or even neural-controlled prosthetic limbs used by injured military personnel. The inventions include cancer-combatting immunotherapies. Most scholars agree that an invention transforms to an innovation because it has been used to create new values. This is not disruptive in nature. Therefore, health innovation is often ‘non-disruptive’ when it is a result of converting existing inventions to new uses (e.g. health app on smart devices, iWatch etc). As innovations in healthcare accelerates rapidly, non-disruptive strategies promise to bring about exponential changes in the areas of disease prevention, more personalized care, and more comprehensive, better-integrated structural designs in healthcare organizations. This non-disruptive change is expected to transform the current encounter-based model to a population-based model, and the paradigm shift shows that disruptive technologies can be used in non-disruptive systems. Thus, disruptive innovation adapts disruptive inventions in new processes that enhance sharing of information/data across care settings and sectors (e.g., hospitals, laboratories, specialists, primary care providers, public health, pharmacies, long-term care) for the purpose of improving health outcomes for the entire population, and at the same time, reducing costs (Simon et al., 2015; Secundo et al., 2019).

The problem is: most hospitals and health systems are basically conservative in nature—without capacity for innovation. But innovation in healthcare management requires a risk-taking mindset in order to maximise huge government expenditures on academic medical research focused on improving clinical practice and basic science. Positive disruption in healthcare innovation, thus, requires collaborative approach and honing of existing innovations (Larisch et al., 2016). In the long run, and with emphasis on disruptive innovation in healthcare, global healthcare management would strengthen rapidly for unprecedented transformation in major domains within the industry—such as more efficient technology-reliant models of care that offer more personalized care in the areas of individual patient’s preferences and genetics (Malik et al., 2017; Huang et al., 2021).

According to WHO, innovation in healthcare can be divided into four categories vis-a-vis:

  • Product innovation: This refers to the launch of new products and services—that may be an improved version of previously known innovations. Changes in the new invention can be analysed using components/materials, technical specifications, updated software version, user friendliness etc.
  • (b) Process innovation: This aspect of innovation focuses on the implementation of a new, innovative strategies that improve work process, productivity, and customer satisfaction. The main objective is to enhance care process and health care delivery using better new techniques, equipment and/or software. Viewed comprehensively, customers willingly pay for process innovation after satisfactory user experience and this exchange consolidates trust, loyalty and long-term sales that benefit stakeholders.
  • (c) Marketing innovation: This emphasizes use of new marketing theories that include redesigning products/services, re-packaging, advertising or price reductions. Quality of products/services usually remains the same, and efforts are geared towards providing more appealing products/services that results in repeated purchase from old and new customers.
  • Organizational innovation: This aspect of innovation focuses on the organizational structure. Activities in organizational innovation includes introduction of new business practices, improving workplace conduciveness, building relationships with competitors/suppliers, lobbying policymakers/regulators in the industry etc.

2.4 Process of Healthcare Innovation

Source: Varkey et al (2008)

2.1.2 Models of Innovation in Healthcare Management

The identified innovation models are organized into seven categories.

  • The Accountable Care Model

The new Accountable Primary Care Model is widely applauded for delivering outcomes due to its scalable, empirical, measurable, programmatic, and transplantable features. Under the ‘Accountable Care’ model, the purpose of healthcare organizations is to incentivize health care providers to maintain high level of professionalism, and more importantly, to take absolute responsibility (i.e. to be accountable) for a patient population. The model also requires health care providers to maximise investment in infrastructure by redesigning care processes capable of providing for coordinated care, high quality and efficient service delivery (Fisher et al., 2009; Kocot et al., 2013).

The goal of care models is to enhance patient care experience, lower per capita costs, and improve the health of populations through innovative health care delivery methods and payment reforms. But earlier attempts to transform care delivery achieved mixed success. For example, Health Maintenance Organizations (HMOs) around 1980s and 1990s applied the traditional fee-for-service (FFS) model to integrate various health care services into a single structure. The idea was to coordinate care and reduce costs by offering lower premiums to patients holding a contract with an HMO organization. Evidence-based research, however, shows that HMOs achieved relative success notwithstanding its widespread adoption. In fact, HMOs were unable to create a lasting health care delivery system and the consequential financial risk to healthcare organizations led to drastic reduction in people’s access to certain services, Care users criticized the decision from HMOs—particularly for their inability to reform payment and delivery systems—and the backlash eventually resulted in minimal application of the care strategy. Moreover, the circumstances surrounding HMO failure showed health technology in that era was at a developing stage and could not empower health providers to efficiently manage patient populations. Use of traditional fee-for-service (FFS) billing was an obstacle towards coordinating care administered to Medicare FFS beneficiaries, thus, health providers were given financial rewards for improving cost efficiency and achieving high performance on thirty-two (32) care quality criteria—similar to the current Accountable Primary Care model used by organizations to achieve both cost and quality success (Smith et al., 2015),

The Accountable Care Model was originally coined by Dr. Elliott Fisher at a public meeting held with the Medicare Payment Advisory Committee (MedPAC) in 2006. In his argument, Dr Fisher proposed that health providers can improve quality and costs if accountability for an individual’s care is shared among all providers within health care continuum (Fisher et al., 2007). The proposal suggested a shift from the strict FFS payment structure to more accountable, value-based reimbursements. Healthcare organizations scrutinized Dr Fisher’s idea and agreed that reform through accountable care was necessary, thus, providers and payers resorted to developing commercial Accountability Care Organizations (ACOs). Under the Accountability Care model, health providers enter into a contractual obligation or other risk-based agreement with insurers that handle financial risk related to care delivery and health outcomes of a defined patient population (Fisher et al., 2007; Muhlestein et al., 2013; Peterson et al., 2014).

  • The Episode-based Payment Initiatives

The Episode-based payment model was created by the Centre for Medicare & Medicaid (CMS) in line with the Affordable Care Act objective of improving patient outcomes at a reduced cost to Medicare. Another aim of the model is to incentivize providers to provide high-quality and cost-efficient care to patients (Malik et al., 2017).

Under the ‘Episode-based Payment Model,’ health care providers are expected to be accountable for payments received as cost of care. They are also responsible for delivering quality service in return for the charges issued during an episode of care that often starts with an unexpected health emergency—such as hospitalization or chemotherapy administration—that may eventually last beyond an expected period of time. This model of care therefore requires adequate preparation for emergency situations (in terms of education, care process, diagnostics, treatment, technology etc). Basically, the total allowable payment accruing from a patient’s care continuum related to a single episode or medical event is predetermined. This implies that there is no separate payment for each service and provider along the sequence of care. All allowable payments are directly issued to healthcare providers and institutions working on the same case after projected costs are ascertained (Ahammad et al., 2015).

The Episode-based Payment approach, just like the Accountable Care version, was a result of the consensus among American citizens that true reform of the health care system requires a shift from FFS payments. This trend was necessitated by a medical culture in the U.S. that places little value and less emphasis on healthcare management activities such as care coordination because it is not explicitly reimbursed. Thus, the need for alternative payment methods (including episode-based payments) is widely considered a policy priority—and focus is on bridging the gap between FFS and capitated payments. But the major challenge to this model is a fragmented care delivery system that both providers and patients find increasingly difficult to navigate. Moreover, FFS payments still compensate volume of care rather than quality or efficiency notwithstanding efforts from industry regulators to correct pricing distortions for different services rendered by healthcare organizations (Wagner et al., 2001).

Generally, discussions on payment reform—particularly in Medicare—have avoided the implications of not including patients in the decision-making process. And policymakers are unnecessarily downplaying the potential impact of payment reforms by making such policy decisions invisible to patients thereby risking biased criticisms. Therefore, a result-oriented way of engaging care users is to provide incentives for them to benefit more efficient, quality and affordable services (Bodenheimer et al., 2002; Coleman et al., 2009).

(c) The Primary Healthcare (PHC) Transformation Model

Primary health care systems are an indispensable mechanism through which every country achieves its health objectives (McSherry & Douglas., 2011). Likewise, primary care providers hold a central position in every national health system, and they represent a key point of contact for patients’ health care needs. The ‘Primary Healthcare (PHC) Transformation Model’ therefore aims at strengthening health facilities in rural areas and increasing people’s access to primary care. The model also promotes good health and emphasizes the importance of reducing the overall cost of health care for individuals and households. Additionally, Wagner et al (2011) asserted that advanced primary care practices, which are widely recognized as ‘patient-centred medical homes (PCMH),’ function more effectively on a team-based approach with concentration on prevention of diseases, utilization of health information technology, efficient coordination of care, and inclusion of patients in the decision-making process led by health care providers (Malik et al., 2017).

Basically, this model focuses on the foundational properties of a PHC system that enables it to deliver high-quality, accessible and efficient health care for the populations. The model therefore answers the following questions Andersen & Kragh., 2010):

(a) Does your PHC system have infrastructure, policies, and human/material resources to deliver primary health care?

(b) Does your PHC system have the basic necessities required for efficient delivery of health care services—such as robust facility management and healthcare management?

(c) Are there effective governance structures to implement and enforce these PHC policies?

(d) Does your PHC system have comprehensive and reliable surveillance systems to detect and respond to changing disease burden and emerging outbreaks?

(e) Has the PHC system established a learning system that prioritizes continual reflection and improvement?

(f) Do communities within the health system contribute to decisions regarding how primary health care is financed, governed, and implemented?

(g) Does the PHC system have a proactive population outreach that provides basic health care services to those in need?

The framework aims at strengthening primary care through multi-payer payment reform. But major objectives are to carry out structural transformations that promotes (i) increased budgetary allocations to the health sector (ii) decreased total health spending (iii) delivery of better care for patients (iv) alignment of payment and incentives across payers, and (v) improved clinical experience for providers. Evidence-based studies show the Primary Care Transformation model has improvement of provider capacity and access as one of its major focus areas (Boxall, P. & Purcell., 2015).

However, proponents of the care model emphasize promotion and incentivization of integrated whole-person and team-based care that includes primary care, physical/behavioural health care, and preventive services. The model is widely accepted across health systems because it encourages collaboration between interested public and private employers to increase spread and scale of its performance. Importantly, the model supports integration of technology in health care delivery. It is well-designed to maximize the tranche of data and evidence that is often available in countries but rarely captured in ways that generate usable information for policymakers or external bodies—including industry regulators. The goal of PHC Transformation model is to unite stakeholders who have complementary knowledge of PHC process within a political system to carry out an objective, comparable assessment of PHC capacity (Burgess et al., 2015).

  • Federal-State Collaborative Health Model

The Federal-State Collaborative Health model is a unique type of integrated care where medical providers and behavioural health providers partner to tackle behavioural health conditions—including mental health issues and substance abuse. This model of health innovation is most popular in the United States, where Medicaid and Children’s Health Insurance Program (CHIP) are controlled by individual states but jointly financed by the federal government and states. Other health initiatives under this model are administered by the participating states (de Luc., 2000).

Figure 2.5: The Federal-State Collaborative Model

Source: Agency for Healthcare Research and Quality (2013)

Comparatively, the Federal-State Collaborative Health framework is closely related to Nigeria’s three-tiered health care framework. Under this model of care, the Collaborative Care team managed by a primary care provider (PCP), includes behavioural healthcare managers, psychiatrists, mental health counsellors, psychologists, social workers, chemical dependency professionals, marriage/family therapists and other mental health professionals who are adequately empowered to perform at their best level. Their main objective is to constantly implement scalable care plan based on evidence-based practice. However, special attention is given to care users who are not meeting their clinical goals. Thus, the model differs from previously analysed frameworks that combine behavioural health services because of the simulated evidence that supports its outcomes, its strict dependence on principles of chronic care delivery, and attention to quality improvement—as well as accountability. The Federal-State Collaborative Care Model combines elements of patient-centred team care, population-based care, measurement-based treatment to target, evidence-based care, and accountable care (Fisher et al., 2009; Gibbs et al., 2017).

Further, the Federal-State Collaboration model of care supports collaboration between primary care and behavioural health providers for effective use of shared care plans that incorporate patient goals. The highpoint of this care model is its ability to integrate mental and physical health care at a familiar location that is accessible and comfortable to care users. This reduces duplication of assessments and increases patient engagement thereby improving access, controlling costs, refining clinical outcomes. Additionally, collaborative efforts under the model of care significantly increases patient satisfaction in a variety of primary care settings—urban, rural, and among veterans (Castaño & Velasco., 2021).

  • The Medicare-Medicaid Model

The Medicare and Medicaid programs were established for different reasons. First, people who registered in both Medicare and Medicaid are commonly known as ‘dual eligible,’ and they benefit from a disproportionate share of expenditures on the programs. Secondly, both Medicare and Medicaid function as a fully integrated, individual-centred system of care which ensures that everyone’s healthcare needs are met—with focus on providing high quality and cost-effective services to the entire population (Said., 2007). As at 2019, according to the Centres for Medicare and Medicaid (CMS), more than 7.7 million U.S. residents were eligible to receive full benefits from federal-owned Medicare and other Medicaid programs from their individual states. This group of beneficiaries are referred to as ‘the Full Benefit Dual Eligible (FBDE) population’ mainly because they are privileged to access health care that integrates both Medicare and Medicaid—although there are slight differences in process/procedure used by individual states (Barth et al., 2020).

The FBDE population comprises of people suffering complex chronic conditions and disabilities—as well as patients who have high social service needs. The FBDE segment requires and uses full-range Medicare and Medicaid services/supports. Other health care demands from the population are medical services, behavioural health support, social services, and long-term care plans. Under the U.S. Medicare and Medicare programs, many patients are allowed to receive care from multiple providers and across multiple health care settings that have little or no coordination across care delivery systems. But the problem is: Medicare and Medicaid programs are not properly structured to take care of person-centred needs of the FBDE group with a well-integrated approach unless they are registered in another integrated program. Yet, even where the patient is willing to enrol in such integrated programs, there is a greater challenge arising from the limited geographic scope and program eligibility/enrolment. Thus, Medicare-Medicaid integrated program options are not available to every individual across the United States, and this implies that millions of people are not covered under integrated whole-person program options. On this premise, the Medicare-Medicaid is relatively inefficient and inequitable (Cumming et al., 2018).

Table 1: Difference between Medicare and Medicaid

S/No.MEDICAREMEDICAID
1Medicare is an insurance program.Medicaid is an assistance program.
2Medical bills are paid from trust funds which those covered have paid into, Patients pay part of costs through deductibles for hospital and other costs. Small monthly premiums are required for non-hospital coveragePatients usually don’t pay the incurred cost of medical services.   But a small co-payment may be required sometimes.
3It serves people over 65 primarily no matter their income level. It also serves younger disabled people and dialysis patients.It serves low-income people of every age.
4Medicare is a federal program. It is basically the same everywhere in the United States and is run by the Centres for Medicare & Medicaid Services, which is an establishment of the federal government.Medicaid is a federal-state program.   It varies from state to state.   It is run by state and local governments within federal guidelines.
  • Payment and Service Delivery Models

Initiatives for the development of testing of payment and service delivery are categorized as a part of health innovation models. For example, some innovations necessary to improve healthcare systems around the world often come from local communities and health care leaders. This model of health innovation, thus, emphasizes research and development (R&D), as well as the inclusion of individuals and households in major decision-making processes. With this collaborative effort, health administrators in every country can partner with regional stakeholders and rural dwellers to accelerate the testing of potentially ‘breakthrough’ models (Nabi et al., 2017).

The Payment and Service Delivery models encourage a shift from the episodic fee-for-service model to a more integrated value-based care delivery and financing framework. This objective requires collaboration between health care and public health to exploit unique windows of opportunities that can lower costs and improve health outcomes. But a major problem is both fields practise different cultures and speak different professional languages. Thus, there is need for health providers to identify more effective and supportive ways that can empower public health to support implementation of patient-centred care that improves health and saves costs across health systems—in both short and long terms.

Under the Payment and Service Delivery model, health providers concentrate on the following four strategic areas aimed at improving revenue drive and maintaining high quality of care: (a) delivering superior outcomes (b) monetizing assets (c) building/acquiring more hospitals and streamlining operations and (d) integrating care across the continuum to decongest the system and reduce total cost (Schnarr et al., 2015)

  • Initiatives to Enhance Adoption of Best Practices

Recent studies in healthcare innovation show that it takes nearly 17 years on average before best practices—if backed by research—are fully integrated into widespread clinical practice (Best et al., 2012). But even when the innovative strategy gains acceptance and is implemented, De Weger et al (2018) noted that the process of applying the knowledge will be very uneven. To achieve success with innovations in healthcare, there is need for partnership between professional societies, federal institutions, physicians, stakeholders, and a broad range of health care providers. The purpose of this network is to properly conduct tests on new models for efficient dissemination of evidence-based best practices. Basically, this model aims at significantly increasing the speed of adopting and implementing innovations in healthcare (Nabi et al., 2017).


Discover more from MEZIESBLOG

Subscribe to get the latest posts sent to your email.


Leave a Reply

Discover more from MEZIESBLOG

Subscribe now to keep reading and get access to the full archive.

Continue reading